tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GB:GSK)
LSE:GSK
UK Market

GlaxoSmithKline (GSK) Income Statement

Compare
1,106 Followers

GlaxoSmithKline Income Statement

Last quarter (Q3 2025), GlaxoSmithKline's total revenue was £8.55B, an increase of 6.68% from the same quarter last year. In Q3, GlaxoSmithKline's net income was £2.01B. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 31.38B£ 30.33B£ 29.32B£ 24.70B£ 34.10B
Gross Profit
£ 21.90B£ 21.25B£ 19.46B£ 16.34B£ 23.12B
Operating Expenses
£ 16.24B£ 14.26B£ 12.78B£ 10.94B£ 14.94B
Depreciation and Amortization
£ 2.55B£ 2.29B£ 2.15B£ 2.12B£ 2.35B
EBITDA
£ 6.67B£ 9.14B£ 8.63B£ 6.45B£ 10.16B
Operating Income
£ 5.66B£ 6.99B£ 6.68B£ 5.41B£ 8.18B
Other Income/Expenses
£ -2.19B£ -929.00M£ -1.05B£ -1.81B£ -1.22B
Pretax Income
£ 3.48B£ 6.06B£ 5.63B£ 3.60B£ 6.97B
Net Income
£ 2.58B£ 4.93B£ 14.96B£ 4.38B£ 5.75B
Per Share Metrics
Basic EPS
£ 0.63£ 1.22£ 3.71£ 1.37£ 1.44
Diluted EPS
£ 0.62£ 1.20£ 3.66£ 1.35£ 1.43
Weighted Average Shares Outstanding
4.08B 4.05B 4.03B 3.20B 3.98B
Weighted Average Shares Outstanding (Diluted)
4.14B 4.11B 4.08B 3.24B 4.03B
Currency in GBP

GlaxoSmithKline Earnings and Revenue History